ATE455102T1 - Inhibitoren von akt (proteinkinase b) - Google Patents

Inhibitoren von akt (proteinkinase b)

Info

Publication number
ATE455102T1
ATE455102T1 AT07798410T AT07798410T ATE455102T1 AT E455102 T1 ATE455102 T1 AT E455102T1 AT 07798410 T AT07798410 T AT 07798410T AT 07798410 T AT07798410 T AT 07798410T AT E455102 T1 ATE455102 T1 AT E455102T1
Authority
AT
Austria
Prior art keywords
akt
inhibitors
protein kinase
kinase
protein
Prior art date
Application number
AT07798410T
Other languages
English (en)
Inventor
Sajan Joseph
Renhua Li
Michael Myers
Aktham Aburub
Jenny Dai
Christopher Schmid
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE455102T1 publication Critical patent/ATE455102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07798410T 2006-06-20 2007-06-12 Inhibitoren von akt (proteinkinase b) ATE455102T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
PCT/US2007/070945 WO2007149730A2 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
ATE455102T1 true ATE455102T1 (de) 2010-01-15

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07798410T ATE455102T1 (de) 2006-06-20 2007-06-12 Inhibitoren von akt (proteinkinase b)

Country Status (28)

Country Link
US (1) US7998977B2 (de)
EP (1) EP2035385B1 (de)
JP (1) JP2009541335A (de)
KR (1) KR101067551B1 (de)
AR (1) AR061240A1 (de)
AT (1) ATE455102T1 (de)
AU (1) AU2007261120A1 (de)
BR (1) BRPI0713136A2 (de)
CA (1) CA2652612A1 (de)
CL (1) CL2007001752A1 (de)
DE (1) DE602007004333D1 (de)
DK (1) DK2035385T3 (de)
DO (1) DOP2008000053A (de)
EA (1) EA015712B1 (de)
EC (1) ECSP088992A (de)
ES (1) ES2336630T3 (de)
HR (1) HRP20100147T1 (de)
IL (1) IL195005A0 (de)
MA (1) MA30757B1 (de)
MX (1) MX2008015904A (de)
NO (1) NO20090289L (de)
PE (1) PE20080338A1 (de)
PL (1) PL2035385T3 (de)
PT (1) PT2035385E (de)
SI (1) SI2035385T1 (de)
TN (1) TNSN08529A1 (de)
TW (1) TW200812970A (de)
WO (1) WO2007149730A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ,インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
AU2014293013A1 (en) 2013-07-26 2016-03-17 Race Oncology Ltd. Combinatorial methods to improve the therapeutic benefit of bisantrene
EP4066836A1 (de) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Behandlung von gelenkerkrankungen
US10123997B2 (en) * 2015-06-15 2018-11-13 Yong Liao Target for treating hepatitis B virus
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
JP7472391B2 (ja) * 2020-07-22 2024-04-22 南京正大天晴制薬有限公司 ジヒドロピリド[2,3-d]ピリミジノン誘導体の塩及び結晶形
US12673061B2 (en) * 2020-07-22 2026-07-07 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. Unit dosage composition of AKT inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136458A0 (en) 2000-05-30 2001-06-14 Peptor Ltd Protein kinase inhibitors
BRPI0408353A (pt) * 2003-03-28 2006-03-21 Lilly Co Eli composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
EP1689719A1 (de) 2003-11-25 2006-08-16 Eli Lilly And Company 7-phenylisochinolin-5-sulfonylaminoderivate als inhibitoren von akt (proteinkinase b)

Also Published As

Publication number Publication date
EP2035385B1 (de) 2010-01-13
DE602007004333D1 (de) 2010-03-04
EP2035385A2 (de) 2009-03-18
MX2008015904A (es) 2009-01-12
CL2007001752A1 (es) 2008-01-18
BRPI0713136A2 (pt) 2012-04-17
NO20090289L (no) 2009-01-19
AU2007261120A1 (en) 2007-12-27
US7998977B2 (en) 2011-08-16
CA2652612A1 (en) 2007-12-27
PT2035385E (pt) 2010-03-01
EA015712B1 (ru) 2011-10-31
KR101067551B1 (ko) 2011-09-27
AR061240A1 (es) 2008-08-13
JP2009541335A (ja) 2009-11-26
TNSN08529A1 (en) 2010-04-14
MA30757B1 (fr) 2009-10-01
TW200812970A (en) 2008-03-16
WO2007149730A3 (en) 2008-04-24
EA200970041A1 (ru) 2009-06-30
DOP2008000053A (es) 2009-01-15
IL195005A0 (en) 2009-08-03
ES2336630T3 (es) 2010-04-14
PL2035385T3 (pl) 2010-06-30
KR20090015978A (ko) 2009-02-12
HRP20100147T1 (hr) 2010-04-30
US20090221633A1 (en) 2009-09-03
DK2035385T3 (da) 2010-03-22
SI2035385T1 (sl) 2010-05-31
PE20080338A1 (es) 2008-04-25
WO2007149730A2 (en) 2007-12-27
ECSP088992A (es) 2009-01-30

Similar Documents

Publication Publication Date Title
DE602007004333D1 (de) Inhibitoren von akt (proteinkinase b)
FR21C1019I2 (fr) Inhibiteurs de kinase de type biaryl-meta-pyrimidine
CY2019009I1 (el) Αναστολεις πρωτεϊνικων κινασων
ATE479434T1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
CY2017012I1 (el) Αναστολεις κινασης τυροσινης bruton
EP2040546A4 (de) Tyrosinkinasehemmer
EP1807077A4 (de) Inhibitoren von c-fms-kinase
BRPI0910668A2 (pt) inibidores de proteína quinases
CR10755A (es) Compounds and compositions as protein kinase inhibitors
BRPI0717317A2 (pt) Modularoes da proteína cinase triazalopiridazina
BRPI0816064A2 (pt) Inibidores da atividade de proteína tirosina cinase.
DE602007014374D1 (de) Ä4,5'ü-bipyrimidinyl-6,4'-diaminderivate als proteinkinase-hemmer
DK1881976T3 (da) Substituerede amidderivater som proteinkinaseinhibitorer
EP1968950A4 (de) Pyrimidinkinaseinhibitoren
ATE518860T1 (de) Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
DOP2007000082A (es) Inhibidores de quinasas de puntos de control
DK1943243T3 (da) Kinase-inhibitorer
ATE433449T1 (de) Kinaseinhibitoren
ATE520664T1 (de) Tyrosinkinase-hemmer
NO20084739L (no) Substituerte 3-cyanopyridiner som protein kinase inhibitorer
BRPI0719883A2 (pt) Inibidores de quinase
EP1904449A4 (de) Checkpoint-kinasehemmer
ZA200809545B (en) Inhibitors of Akt (protein kinase B)
EP1954717A4 (de) Peptid-hemmer von abl-kinase
ZA200902826B (en) IKK-B Serine-Threonine protein kinase inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2035385

Country of ref document: EP